CRISPR QC’s Series A Round Secures Funding from Xcellerant Ventures

San Diego-Based CRISPR QC Secures Series A Funding from Xcellerant Ventures

San Diego-based biotechnology startup, CRISPR QC, has announced securing funding from Xcellerant Ventures in its ongoing Series A funding round. Although the exact amount of the deal has not been disclosed, this funding is expected to drive further developments in the company’s CRISPR Analytics Platform.